What is the CVSS score of CVE-2023-26089?

CVE-2023-26089 has a CVSS 3.1 base score of 9.8 (Critical). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.1%.

Iuclid CVE-2023-26089

CRITICAL

Use of Hard-coded Credentials (CWE-798)

2023-05-02 cve@mitre.org

Authentication Bypass Iuclid

9.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

9.8 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

May 02, 2023 - 20:15 nvd

CRITICAL 9.8

DescriptionNVD

European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.

AnalysisAI

European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Use of Hard-coded Credentials (CWE-798), which allows attackers to gain access using credentials embedded in source code. European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5. Affected products include: Echa.Europa Iuclid. Version information: before 6.27.6.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Remove hard-coded credentials, use environment variables or secrets management, rotate exposed credentials immediately.